PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30633770 ↗2019Reported benefit

Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.

MouseChemical/toxinC57BL/6Femalen = Five groups, n=9 per group, 45 miceIntraperitonealCaptopril 10 mg/kg per day and chymostatin 10 mg/kg per day…Concurrent with the 3-day aristolochic acid dosing

Model: Aristolochic acid I-induced acute nephropathy, 15 mg/kg per day intraperitoneally for 3 days to a cumulative dose of 45 mg/kg

Chymase inhibition, and particularly combined ACE and chymase inhibition, lowered renal angiotensin II, reduced serum blood urea nitrogen and creatinine, proteinuria, inflammatory cytokines and tubular injury, and reduced p-MEK/p-ERK1/2 activation, though injury was ameliorated rather than prevente…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.